Mechanicsville, VA, United States of America

Aron Sanyal


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 23(Granted Patents)


Company Filing History:


Years Active: 1999

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in Cardiovascular Treatments by Aron Sanyal

Introduction

Aron Sanyal is an innovative inventor based in Mechanicsville, VA (US). He has made significant contributions to the field of cardiovascular medicine through his research and patent work. His focus on cannabinoid compounds has opened new avenues for treating various medical conditions.

Latest Patents

Aron Sanyal holds a patent for "Cardiovascular uses of cannabinoid compounds." This patent addresses the treatment of hemorrhagic shock and other conditions associated with excessive vasoconstriction, such as hypertension, peripheral vascular disease, cirrhosis of the liver, and certain forms of angina pectoris. The patent highlights the therapeutic potential of using agonists of CB1 receptors and other cannabinoid receptors. Additionally, it discusses the use of drugs that selectively block CB1 receptors in cases of septic shock and cirrhosis of the liver, where hypotension is caused by macrophage activation due to bacterial endotoxin.

Career Highlights

Aron Sanyal is affiliated with Virginia Commonwealth University, where he conducts research and collaborates with other experts in the field. His work has garnered attention for its innovative approach to treating cardiovascular issues through cannabinoid compounds.

Collaborations

Some of his notable coworkers include George Kunos and Karoly Varga, who have contributed to the research and development of cannabinoid-based therapies.

Conclusion

Aron Sanyal's work exemplifies the intersection of innovation and medicine, particularly in the realm of cardiovascular treatments. His patent on cannabinoid compounds represents a significant advancement in therapeutic options for patients suffering from various conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…